Vincenzo Mercurio1, Wendy Fitzgerald1, Christophe Vanpouille1, Ivan Molodtsov2, Leonid Margolis1. 1. Section on Intercellular Interactions, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD , USA. 2. Clinical City Hospital named after I.V.Davydovsky, Moscow Department of Healthcare, Moscow, Russia.
Abstract
OBJECTIVE: HIV-1 infection triggers immune activation, as reflected by the upregulation of various cytokines. This immune activation remains elevated despite antiretroviral therapy (ART) and leads to early age-related diseases. Here, we addressed the mechanisms of sustained immune activation in HIV-1-infected human lymphoid tissues ex vivo. DESIGN/ METHOD: We investigated several potential causes of immunoactivation, including: a proinflammatory effect of ART drugs themselves; an early HIV-1-triggered cytokine storm, which could in turn trigger a sustained cytokine dysregulation; herpesvirus reactivation; HIV-1 protein release; and production of defective virions and extracellular vesicles. Tissue immune activation was evaluated from measurements of cytokines in culture medium using multiplexed immunoassays. RESULTS: Neither ART itself nor simulated cytokine storms nor exogenously added HIV-1 proteins triggered a sustained cytokine upregulation. In contrast, defective (replicative-incompetent) virions and extracellular vesicles induced sustained cytokine upregulation, as did infectious virus. Tissue immune activation was accompanied by reactivation of cytomegalovirus. CONCLUSION: The system of ex-vivo human lymphoid tissue allowed investigation, under laboratory-controlled conditions, of possible mechanisms involved in persistent immune activation in HIV-1 patients under ART. Mechanisms of this immunoactivation identified in ex-vivo tissues may indicate potential therapeutic targets for restoration of immune system homeostasis in HIV-1-infected patients.
OBJECTIVE: HIV-1 infection triggers immune activation, as reflected by the upregulation of various cytokines. This immune activation remains elevated despite antiretroviral therapy (ART) and leads to early age-related diseases. Here, we addressed the mechanisms of sustained immune activation in HIV-1-infected human lymphoid tissues ex vivo. DESIGN/ METHOD: We investigated several potential causes of immunoactivation, including: a proinflammatory effect of ART drugs themselves; an early HIV-1-triggered cytokine storm, which could in turn trigger a sustained cytokine dysregulation; herpesvirus reactivation; HIV-1 protein release; and production of defective virions and extracellular vesicles. Tissue immune activation was evaluated from measurements of cytokines in culture medium using multiplexed immunoassays. RESULTS: Neither ART itself nor simulated cytokine storms nor exogenously added HIV-1 proteins triggered a sustained cytokine upregulation. In contrast, defective (replicative-incompetent) virions and extracellular vesicles induced sustained cytokine upregulation, as did infectious virus. Tissue immune activation was accompanied by reactivation of cytomegalovirus. CONCLUSION: The system of ex-vivo human lymphoid tissue allowed investigation, under laboratory-controlled conditions, of possible mechanisms involved in persistent immune activation in HIV-1 patients under ART. Mechanisms of this immunoactivation identified in ex-vivo tissues may indicate potential therapeutic targets for restoration of immune system homeostasis in HIV-1-infected patients.
Authors: Brian S Conklin; Weiping Fu; Peter H Lin; Alan B Lumsden; Qizhi Yao; Changyi Chen Journal: Cardiovasc Res Date: 2004-07-01 Impact factor: 10.787
Authors: Angélique Biancotto; Jean-Charles Grivel; Sarah J Iglehart; Christophe Vanpouille; Andrea Lisco; Scott F Sieg; Robert Debernardo; Kristen Garate; Benigno Rodriguez; Leonid B Margolis; Michael M Lederman Journal: Blood Date: 2007-02-08 Impact factor: 22.113
Authors: Angélique Biancotto; Sarah J Iglehart; Andrea Lisco; Christophe Vanpouille; Jean-Charles Grivel; Nell S Lurain; Patricia S Reichelderfer; Leonid B Margolis Journal: AIDS Res Hum Retroviruses Date: 2008-03 Impact factor: 2.205
Authors: Mark A Bernard; Hui Zhao; Simon C Yue; Asha Anandaiah; Henry Koziel; Souvenir D Tachado Journal: PLoS One Date: 2014-09-05 Impact factor: 3.240
Authors: Sukrutha Chettimada; David R Lorenz; Vikas Misra; Simon T Dillon; R Keith Reeves; Cordelia Manickam; Susan Morgello; Gregory D Kirk; Shruti H Mehta; Dana Gabuzda Journal: Sci Rep Date: 2018-05-08 Impact factor: 4.379
Authors: Jonathan Burnie; Arvin Tejnarine Persaud; Laxshaginee Thaya; Qingbo Liu; Huiyi Miao; Stephen Grabinsky; Vanessa Norouzi; Paolo Lusso; Vera A Tang; Christina Guzzo Journal: Retrovirology Date: 2022-05-21 Impact factor: 3.768